Global Anlotinib Market Growth (Status and Outlook) 2023-2029

March 2023 | 60 pages | ID: GF601FCA882EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Anlotinib Industry Forecast” looks at past sales and reviews total world Anlotinib sales in 2022, providing a comprehensive analysis by region and market sector of projected Anlotinib sales for 2023 through 2029. With Anlotinib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anlotinib industry.

This Insight Report provides a comprehensive analysis of the global Anlotinib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anlotinib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anlotinib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anlotinib and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anlotinib.

The global Anlotinib market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Anlotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Anlotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Anlotinib is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Anlotinib players cover CHIA TAI TIANQING. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Anlotinib market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• 8mg Capsules
• 10mg Capsules
• 12mg Capsules

Segmentation by application

• Non-small Cell Lung Cancer
• Ovarian Cancer
• Soft Tissue Sarcoma
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• CHIA TAI TIANQING

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anlotinib Market Size 2018-2029
  2.1.2 Anlotinib Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Anlotinib Segment by Type
  2.2.1 8mg Capsules
  2.2.2 10mg Capsules
  2.2.3 12mg Capsules
2.3 Anlotinib Market Size by Type
  2.3.1 Anlotinib Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Anlotinib Market Size Market Share by Type (2018-2023)
2.4 Anlotinib Segment by Application
  2.4.1 Non-small Cell Lung Cancer
  2.4.2 Ovarian Cancer
  2.4.3 Soft Tissue Sarcoma
  2.4.4 Other
2.5 Anlotinib Market Size by Application
  2.5.1 Anlotinib Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Anlotinib Market Size Market Share by Application (2018-2023)

3 ANLOTINIB MARKET SIZE BY PLAYER

3.1 Anlotinib Market Size Market Share by Players
  3.1.1 Global Anlotinib Revenue by Players (2018-2023)
  3.1.2 Global Anlotinib Revenue Market Share by Players (2018-2023)
3.2 Global Anlotinib Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANLOTINIB BY REGIONS

4.1 Anlotinib Market Size by Regions (2018-2023)
4.2 Americas Anlotinib Market Size Growth (2018-2023)
4.3 APAC Anlotinib Market Size Growth (2018-2023)
4.4 Europe Anlotinib Market Size Growth (2018-2023)
4.5 Middle East & Africa Anlotinib Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Anlotinib Market Size by Country (2018-2023)
5.2 Americas Anlotinib Market Size by Type (2018-2023)
5.3 Americas Anlotinib Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anlotinib Market Size by Region (2018-2023)
6.2 APAC Anlotinib Market Size by Type (2018-2023)
6.3 APAC Anlotinib Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Anlotinib by Country (2018-2023)
7.2 Europe Anlotinib Market Size by Type (2018-2023)
7.3 Europe Anlotinib Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anlotinib by Region (2018-2023)
8.2 Middle East & Africa Anlotinib Market Size by Type (2018-2023)
8.3 Middle East & Africa Anlotinib Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANLOTINIB MARKET FORECAST

10.1 Global Anlotinib Forecast by Regions (2024-2029)
  10.1.1 Global Anlotinib Forecast by Regions (2024-2029)
  10.1.2 Americas Anlotinib Forecast
  10.1.3 APAC Anlotinib Forecast
  10.1.4 Europe Anlotinib Forecast
  10.1.5 Middle East & Africa Anlotinib Forecast
10.2 Americas Anlotinib Forecast by Country (2024-2029)
  10.2.1 United States Anlotinib Market Forecast
  10.2.2 Canada Anlotinib Market Forecast
  10.2.3 Mexico Anlotinib Market Forecast
  10.2.4 Brazil Anlotinib Market Forecast
10.3 APAC Anlotinib Forecast by Region (2024-2029)
  10.3.1 China Anlotinib Market Forecast
  10.3.2 Japan Anlotinib Market Forecast
  10.3.3 Korea Anlotinib Market Forecast
  10.3.4 Southeast Asia Anlotinib Market Forecast
  10.3.5 India Anlotinib Market Forecast
  10.3.6 Australia Anlotinib Market Forecast
10.4 Europe Anlotinib Forecast by Country (2024-2029)
  10.4.1 Germany Anlotinib Market Forecast
  10.4.2 France Anlotinib Market Forecast
  10.4.3 UK Anlotinib Market Forecast
  10.4.4 Italy Anlotinib Market Forecast
  10.4.5 Russia Anlotinib Market Forecast
10.5 Middle East & Africa Anlotinib Forecast by Region (2024-2029)
  10.5.1 Egypt Anlotinib Market Forecast
  10.5.2 South Africa Anlotinib Market Forecast
  10.5.3 Israel Anlotinib Market Forecast
  10.5.4 Turkey Anlotinib Market Forecast
  10.5.5 GCC Countries Anlotinib Market Forecast
10.6 Global Anlotinib Forecast by Type (2024-2029)
10.7 Global Anlotinib Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 CHIA TAI TIANQING
  11.1.1 CHIA TAI TIANQING Company Information
  11.1.2 CHIA TAI TIANQING Anlotinib Product Offered
  11.1.3 CHIA TAI TIANQING Anlotinib Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 CHIA TAI TIANQING Main Business Overview
  11.1.5 CHIA TAI TIANQING Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Anlotinib Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of 8mg Capsules
Table 3. Major Players of 10mg Capsules
Table 4. Major Players of 12mg Capsules
Table 5. Anlotinib Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Anlotinib Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Anlotinib Market Size Market Share by Type (2018-2023)
Table 8. Anlotinib Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Anlotinib Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Anlotinib Market Size Market Share by Application (2018-2023)
Table 11. Global Anlotinib Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Anlotinib Revenue Market Share by Player (2018-2023)
Table 13. Anlotinib Key Players Head office and Products Offered
Table 14. Anlotinib Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Anlotinib Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Anlotinib Market Size Market Share by Regions (2018-2023)
Table 19. Global Anlotinib Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Anlotinib Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Anlotinib Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Anlotinib Market Size Market Share by Country (2018-2023)
Table 23. Americas Anlotinib Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Anlotinib Market Size Market Share by Type (2018-2023)
Table 25. Americas Anlotinib Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Anlotinib Market Size Market Share by Application (2018-2023)
Table 27. APAC Anlotinib Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Anlotinib Market Size Market Share by Region (2018-2023)
Table 29. APAC Anlotinib Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Anlotinib Market Size Market Share by Type (2018-2023)
Table 31. APAC Anlotinib Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Anlotinib Market Size Market Share by Application (2018-2023)
Table 33. Europe Anlotinib Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Anlotinib Market Size Market Share by Country (2018-2023)
Table 35. Europe Anlotinib Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Anlotinib Market Size Market Share by Type (2018-2023)
Table 37. Europe Anlotinib Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Anlotinib Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Anlotinib Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Anlotinib Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Anlotinib Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Anlotinib Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Anlotinib Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Anlotinib Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Anlotinib
Table 46. Key Market Challenges & Risks of Anlotinib
Table 47. Key Industry Trends of Anlotinib
Table 48. Global Anlotinib Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Anlotinib Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Anlotinib Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Anlotinib Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. CHIA TAI TIANQING Details, Company Type, Anlotinib Area Served and Its Competitors
Table 53. CHIA TAI TIANQING Anlotinib Product Offered
Table 54. CHIA TAI TIANQING Anlotinib Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. CHIA TAI TIANQING Main Business
Table 56. CHIA TAI TIANQING Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Anlotinib Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anlotinib Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Anlotinib Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Anlotinib Sales Market Share by Country/Region (2022)
Figure 8. Anlotinib Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Anlotinib Market Size Market Share by Type in 2022
Figure 10. Anlotinib in Non-small Cell Lung Cancer
Figure 11. Global Anlotinib Market: Non-small Cell Lung Cancer (2018-2023) & ($ Millions)
Figure 12. Anlotinib in Ovarian Cancer
Figure 13. Global Anlotinib Market: Ovarian Cancer (2018-2023) & ($ Millions)
Figure 14. Anlotinib in Soft Tissue Sarcoma
Figure 15. Global Anlotinib Market: Soft Tissue Sarcoma (2018-2023) & ($ Millions)
Figure 16. Anlotinib in Other
Figure 17. Global Anlotinib Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Anlotinib Market Size Market Share by Application in 2022
Figure 19. Global Anlotinib Revenue Market Share by Player in 2022
Figure 20. Global Anlotinib Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Anlotinib Market Size 2018-2023 ($ Millions)
Figure 22. APAC Anlotinib Market Size 2018-2023 ($ Millions)
Figure 23. Europe Anlotinib Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Anlotinib Market Size 2018-2023 ($ Millions)
Figure 25. Americas Anlotinib Value Market Share by Country in 2022
Figure 26. United States Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Anlotinib Market Size Market Share by Region in 2022
Figure 31. APAC Anlotinib Market Size Market Share by Type in 2022
Figure 32. APAC Anlotinib Market Size Market Share by Application in 2022
Figure 33. China Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Anlotinib Market Size Market Share by Country in 2022
Figure 40. Europe Anlotinib Market Size Market Share by Type (2018-2023)
Figure 41. Europe Anlotinib Market Size Market Share by Application (2018-2023)
Figure 42. Germany Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Anlotinib Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Anlotinib Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Anlotinib Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Anlotinib Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Anlotinib Market Size 2024-2029 ($ Millions)
Figure 56. APAC Anlotinib Market Size 2024-2029 ($ Millions)
Figure 57. Europe Anlotinib Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Anlotinib Market Size 2024-2029 ($ Millions)
Figure 59. United States Anlotinib Market Size 2024-2029 ($ Millions)
Figure 60. Canada Anlotinib Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Anlotinib Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Anlotinib Market Size 2024-2029 ($ Millions)
Figure 63. China Anlotinib Market Size 2024-2029 ($ Millions)
Figure 64. Japan Anlotinib Market Size 2024-2029 ($ Millions)
Figure 65. Korea Anlotinib Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Anlotinib Market Size 2024-2029 ($ Millions)
Figure 67. India Anlotinib Market Size 2024-2029 ($ Millions)
Figure 68. Australia Anlotinib Market Size 2024-2029 ($ Millions)
Figure 69. Germany Anlotinib Market Size 2024-2029 ($ Millions)
Figure 70. France Anlotinib Market Size 2024-2029 ($ Millions)
Figure 71. UK Anlotinib Market Size 2024-2029 ($ Millions)
Figure 72. Italy Anlotinib Market Size 2024-2029 ($ Millions)
Figure 73. Russia Anlotinib Market Size 2024-2029 ($ Millions)
Figure 74. Spain Anlotinib Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Anlotinib Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Anlotinib Market Size 2024-2029 ($ Millions)
Figure 77. Israel Anlotinib Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Anlotinib Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Anlotinib Market Size 2024-2029 ($ Millions)
Figure 80. Global Anlotinib Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Anlotinib Market Size Market Share Forecast by Application (2024-2029)